(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Hospital Care Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets's offering.

Fully revised and updated, the report provides details of 726 hospital care deals from 2016 to 2025.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Hospital Care Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hospital care deals entered into by the world's leading biopharma companies.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of the report provide an overview of hospital care dealmaking, with Chapter 1 serving as an introduction and Chapter 2 analyzing the trends in hospital care dealmaking. Chapter 3 delves into financial deal terms, detailing deals in the hospital care sector by headline value, upfront payment, milestone payment, and royalty rates. Chapter 4 reviews the top 25 most active biopharma companies, offering links to contracts available via the SEC. Chapter 5 covers a detailed examination of hospital care deals since 2016, and Chapter 6 organizes hospital care deals by therapeutic target. The report includes numerous tables and figures to illustrate dealmaking trends and activities since 2016.
Hospital Care Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse hospital care collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus, and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess the suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in hospital care dealmaking
2.1. Introduction
2.2. Hospital care partnering over the years
2.3. Hospital care partnering by deal type
2.4. Hospital care partnering by industry sector
2.5. Hospital care partnering by stage of development
2.6. Hospital care partnering by technology type
2.7. Hospital care partnering by therapeutic indication
Chapter 3 - Financial deal terms for hospital care partnering
3.1. Introduction
3.2. Disclosed financials terms for hospital care partnering
3.3. Hospital care partnering headline values
3.4. Hospital care deal upfront payments
3.5. Hospital care deal milestone payments
3.6. Hospital care royalty rates
Chapter 4 - Leading hospital care deals and dealmakers
4.1. Introduction
4.2. Most active in hospital care partnering
4.3. List of most active dealmakers in hospital care
4.4. Top hospital care deals by value
Chapter 5 - Hospital care contract document directory
5.1. Introduction
5.2. Hospital care partnering deals where contract document available
Chapter 6 - Hospital care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by hospital care therapeutic target
Companies Featured

• 3M
• Accenture
• Advanced Development of Additive Manufacturing
• AgNovos Healthcare
• Albert Einstein College of Medicine
• Allergan
• Amgen
• Ancestry
• Apple
• Arthrex
• Asahi Kasei
• AstraZeneca
• B Braun
• Becton Dickinson
• Boston Scientific
• Catalent
• Charles River Laboratories
• Children's Hospital of Philadelphia
• Cleveland Clinic
• Columbia University
• Cook Biotech
• DePuy
• Defense Advanced Research Projects Agency
• Department of Defense
• Duke University
• Eli Lilly
• EvidNet
• GE Healthcare
• German Heart Centre Berlin
• Google
• Grifols
• HP
• IBM Watson Health
• Indiana University
• Intel
• Intuitive Surgical
• Janssen Biotech
• Johns Hopkins University
• Johnson & Johnson
• Karl Storz
• Lexington Medical
• Massachusetts General Hospital
• Mayo Clinic
• Medtronic
• Microsoft
• National Institutes of Health
• NASA
• Novartis
• Pfizer
• Philips

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19112025004107003653ID1110368222